# Nafcillin

NDC: 63323-327
Generic name: NAFCILLIN SODIUM
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20110630

FDA application: ANDA090002

## Active ingredients

- NAFCILLIN SODIUM: 1 g/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-327"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-327
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c39721a3-7b22-4720-9dbd-bc82f03d2af7